Hepatology

Medications

Researchers develop new drugs for treating polycystic hepatorena

Polycystic hepatorenal diseases are hereditary genetic disorders characterized by the progressive development of multiple symptomatic cysts in the kidneys and/or liver that may cause alterations in the function of those organs ...

Oncology & Cancer

'Genetic rewiring' drives cancer's drug resistance

A tiny molecule of RNA—known as 'micro RNA' - plays a key role in 'rewiring' cancer cells so they can resist the effects of chemotherapy, a new study reveals.

page 6 from 23